rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Karen Deborah Chagin

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Context Therapeutics.

In numbers

Trades disclosed
3
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
9 Jun 2025
Last trade
19 Feb 2026
Last filed
23 Feb 2026

Companies traded

Where they are an officer
CNTX Context TherapeuticsOfficer · Biotechnology · last 19 Feb 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
19 Feb 2026filed 23 Feb 2026CNTX Context Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—290,000 at $0.00filing
19 Feb 2026filed 23 Feb 2026CNTX Context Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—290,000 at $0.00filing
9 Jun 2025filed 9 Jun 2025CNTX Context Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—153,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Philip W. KantoffDirector · Director at Context Therapeutics, filing Form 4 there in the last year
Karen L. SmithDirector · Director at Context Therapeutics, filing Form 4 there in the last year
Luke Nathaniel WalkerDirector · Director at Context Therapeutics, filing Form 4 there in the last year
Andy PasternakDirector · Director at Context Therapeutics, filing Form 4 there in the last year
Linda WestDirector · Director at Context Therapeutics, filing Form 4 there in the last year